Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIA vs EDA for Pain After Total Knee Arthroplasty
NCT00562627Phase 4Completed
- Sponsor
- Bærum Sykehus
- Start
- Nov 2007
- Primary completion
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection, epinephrine, ketorolac and morphine in knee osteoarthritis (OA), sponsored by Bærum Sykehus. Started Nov 2007; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionepinephrineketorolacmorphine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00562627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562627.